Trademark: 88764198
Status Date
Tuesday, August 22, 2023
Registration Number
7145870
Registration Date
Tuesday, August 22, 2023
Filing Date
Friday, January 17, 2020
Published for Opposition
Tuesday, May 19, 2020
5 Pharmaceutical preparations and substances for use in gene therapy, genetic medicines and regenerative therapies; pharmaceuticals and medical preparations and substances for genetically based diseases and rare disorders; pharmaceuticals and medical preparations and substances for use in the prevention and treatment of diseases and disorders of the central nervous system; medicines for human purposes, namely, for treating genetically based diseases and disorders; pharmaceutical compositions, namely, viral vectors for use in the delivery of gene therapy; pharmaceutical compositions, namely, viral vectors for use in the delivery of gene therapy for rare monogenic central nervous system diseases; pharmaceutical compositions containing adeno-associated virus (AAV) vectors for a system delivering genes to biological cells for use in the treatment of diseases, sicknesses, and disorders
42 Pharmaceutical research and development; clinical research in the field of genetic medicine, gene therapy and regenerative medicines; testing, inspection, research, or development of pharmaceutical preparations and substances for genetic medicine, gene therapy and regenerative medicines; biological information analysis, namely, genetic testing for medical research purposes; scientific research in the fields of medicine, genetics, genetic medicines, regenerative medicines, gene therapy, biologics, and central nervous system diseases; providing medical and scientific research information in the fields of pharmaceuticals, genetics and clinical trials; medical and scientific research, namely, conducting clinical trials for others; compiling scientific and clinical data, in particular patient data and data from clinical studies, for research purposes in the fields of medicine, genetics, genetics medicines, regenerative medicines, gene therapy, biologics, and rare disease
Aug 22, 2023
Notice Of Registration Confirmation Emailed
Aug 22, 2023
Registered-Principal Register
Jul 18, 2023
Notice Of Acceptance Of Statement Of Use E-Mailed
Jul 17, 2023
Allowed Principal Register - Sou Accepted
Jul 17, 2023
Statement Of Use Processing Complete
Jul 14, 2023
Use Amendment Filed
Jul 14, 2023
Teas Statement Of Use Received
Jan 28, 2023
Notice Of Approval Of Extension Request E-Mailed
Jan 27, 2023
Sou Extension 5 Granted
Jan 12, 2023
Sou Extension 5 Filed
Jan 26, 2023
Case Assigned To Intent To Use Paralegal
Jan 12, 2023
Sou Teas Extension Received
Jul 8, 2022
Notice Of Approval Of Extension Request E-Mailed
Jul 6, 2022
Sou Extension 4 Granted
Jul 6, 2022
Sou Extension 4 Filed
Jul 6, 2022
Sou Teas Extension Received
Jan 15, 2022
Notice Of Approval Of Extension Request E-Mailed
Jan 13, 2022
Sou Extension 3 Granted
Jan 13, 2022
Sou Extension 3 Filed
Jan 13, 2022
Sou Teas Extension Received
Jul 8, 2021
Notice Of Approval Of Extension Request E-Mailed
Jul 6, 2021
Sou Extension 2 Granted
Jul 6, 2021
Sou Extension 2 Filed
Jul 6, 2021
Sou Teas Extension Received
Jan 6, 2021
Notice Of Approval Of Extension Request E-Mailed
Jan 4, 2021
Sou Extension 1 Granted
Jan 4, 2021
Sou Extension 1 Filed
Jan 4, 2021
Sou Teas Extension Received
Jul 14, 2020
Noa E-Mailed - Sou Required From Applicant
May 19, 2020
Official Gazette Publication Confirmation E-Mailed
May 19, 2020
Published For Opposition
Apr 29, 2020
Notification Of Notice Of Publication E-Mailed
Apr 13, 2020
Assigned To Lie
Apr 6, 2020
Approved For Pub - Principal Register
Apr 6, 2020
Examiner's Amendment Entered
Apr 6, 2020
Notification Of Examiners Amendment E-Mailed
Apr 6, 2020
Examiners Amendment E-Mailed
Apr 6, 2020
Examiners Amendment -Written
Apr 6, 2020
Assigned To Examiner
Jan 24, 2020
New Application Office Supplied Data Entered
Jan 21, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
